• Mon, April 13, 2020

by: WOPRAI

Vladimir Bystricky Initiated (CARR) at Hold and Held Target at $17 on, Apr 13th, 2020

by: WOPRAI

Craig Ellis Maintained (AOSL) at Hold with Decreased Target to $8 on, Apr 13th, 2020

by: WOPRAI

Armintas Sinkevicius Maintained (AN) at Sell with Increased Target to $27 on, Apr 13th, 2020

by: WOPRAI

Hans Chung Maintained (BABA) at Buy with Increased Target to $255 on, Apr 13th, 2020

by: WOPRAI

Jerry Liu Maintained (BABA) at Strong Buy with Decreased Target to $265 on, Apr 13th, 2020

by: WOPRAI

Raghuram Selvaraju Initiated (BBIO) at Strong Buy and Held Target at $50 on, Apr 13th, 2020

by: WOPRAI

Lawrence Keusch Maintained (BAX) at Buy with Increased Target to $97 on, Apr 13th, 2020

by: WOPRAI

Steve Moss Upgraded (BANC) to Hold and Increased Target to $11 on, Apr 13th, 2020

by: WOPRAI

Dave Rochester Maintained (AXP) at Strong Buy with Decreased Target to $112 on, Apr 13th, 2020

by: WOPRAI

Michael Baker Maintained (AZO) at Strong Buy on, Apr 13th, 2020

by: WOPRAI

Yun Kim Upgraded (ZS) to Strong Buy and Increased Target to $75 on, Apr 13th, 2020

by: WOPRAI

Steve Moss Maintained (ZION) at Strong Buy with Decreased Target to $39 on, Apr 13th, 2020

by: WOPRAI

Lawrence Keusch Maintained (ZBH) at Strong Buy with Decreased Target to $136 on, Apr 13th, 2020

by: WOPRAI

Mark Delaney Downgraded (BDC) to Strong Sell on, Apr 13th, 2020

by: WOPRAI

Courtney Yakavonis Maintained (ALSN) at Hold with Increased Target to $44 on, Apr 13th, 2020

by: WOPRAI

David Motemaden Upgraded (ALL) to Buy and Decreased Target to $119 on, Apr 13th, 2020

by: WOPRAI

Asthika Goonewardene Initiated (ALLO) at Strong Buy and Held Target at $29 on, Apr 13th, 2020

by: WOPRAI

Craig Ellis Maintained (AMAT) at Hold with Increased Target to $53 on, Apr 13th, 2020

by: WOPRAI

Stephen Laws Maintained (ACRE) at Strong Buy with Decreased Target to $11 on, Apr 13th, 2020

by: WOPRAI

Derek Hewett Upgraded (ARCC) to Strong Buy on, Apr 13th, 2020

by: WOPRAI

Chris Kotowski Maintained (ARCC) at Buy with Decreased Target to $16 on, Apr 13th, 2020

by: WOPRAI

James Picariello Maintained (APTV) at Buy with Increased Target to $77 on, Apr 13th, 2020

by: WOPRAI

Dave Kang Maintained (VIAV) at Strong Buy and Held Target at $17 on, Apr 13th, 2020

by: WOPRAI

Ross Gilardi Downgraded (URI) to Hold on, Apr 13th, 2020

by: WOPRAI

Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $53 on, Apr 13th, 2020

by: WOPRAI

Tien-Tsin Huang Maintained (ACN) at Buy with Increased Target to $197 on, Apr 13th, 2020

by: WOPRAI

Craig Ellis Maintained (ACLS) at Hold with Increased Target to $22 on, Apr 13th, 2020

by: WOPRAI

Matt Miksic Maintained (ABT) at Buy with Increased Target to $95 on, Apr 13th, 2020

by: WOPRAI

Navin Jacob Maintained (ABBV) at Strong Buy with Decreased Target to $96 on, Apr 13th, 2020

by: WOPRAI

Stephen Laws Maintained (ABR) at Buy with Decreased Target to $9.5 on, Apr 13th, 2020

by: WOPRAI

Armintas Sinkevicius Maintained (ABG) at Hold with Increased Target to $61 on, Apr 13th, 2020

by: WOPRAI

Michael Baker Maintained (AAP) at Hold with Decreased Target to $107 on, Apr 13th, 2020

by: WOPRAI

Chris Caso Maintained (AAPL) at Buy with Decreased Target to $76 on, Apr 13th, 2020

by: WOPRAI

Toni Sacconaghi Maintained (AAPL) at Hold with Decreased Target to $285 on, Apr 13th, 2020

by: WOPRAI

Douglas Mitchelson Maintained (T) at Hold with Decreased Target to $33 on, Apr 13th, 2020

by: WOPRAI

Kristen Stewart Downgraded (SYK) to Sell on, Apr 13th, 2020

by: WOPRAI

Lawrence Keusch Maintained (SYK) at Buy with Decreased Target to $205 on, Apr 13th, 2020

by: WOPRAI

Chris Caso Maintained (SWKS) at Buy with Decreased Target to $120 on, Apr 13th, 2020

by: WOPRAI

Craig Ellis Maintained (SWKS) at Strong Buy with Increased Target to $115 on, Apr 13th, 2020

by: WOPRAI

Stephen Laws Maintained (STWD) at Buy with Decreased Target to $18 on, Apr 13th, 2020

by: WOPRAI

Joseph Moore Downgraded (TXN) to Sell and Decreased Target to $101 on, Apr 13th, 2020

by: WOPRAI

Timothy Wojs Maintained (TT) at Hold with Decreased Target to $90 on, Apr 13th, 2020

by: WOPRAI

David Motemaden Upgraded (TRV) to Hold and Decreased Target to $117 on, Apr 13th, 2020

by: WOPRAI

Stephen Laws Maintained (TRTX) at Buy with Decreased Target to $10 on, Apr 13th, 2020

by: WOPRAI

Scott Berg Maintained (WDAY) at Strong Buy with Decreased Target to $175 on, Apr 13th, 2020

by: WOPRAI

Linda Bolton Weiser Maintained (WDFC) at Strong Buy with Decreased Target to $212 on, Apr 13th, 2020

by: WOPRAI

Jason Mills Maintained (ATRC) at Strong Buy with Decreased Target to $41 on, Apr 13th, 2020

by: WOPRAI

John McNulty Upgraded (ASH) to Buy and Decreased Target to $75 on, Apr 13th, 2020

Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $53 on, Apr 13th, 2020

Raghuram Selvaraju of HC Wainwright & Co., Maintained "UroGen Pharma Ltd." (URGN) at Strong Buy with Decreased Target from $75 to $53 on, Apr 13th, 2020.

Raghuram has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram

  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $45 on, Monday, April 6th, 2020

Like: 👍